Haemonetics Corporation remains a high-quality blood-management franchise with strong TEG and plasma software moats, but recent growth has paused due to portfolio shifts and competition. Q1 FY2026 ...

BOSTON, April 4, 2024 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced ...

Haemonetics Corporation (NYSE:HAE) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. On ...

Global Blood Bank Management System (BBMS) Market Size, Status and Forecast 2020-2026 , Covid 19 Outbreak Impact research report added by Report Ocean, predicts the industry's performance for the ...

Haemonetics Corp. has announced it has completed the acquisition of the business assets of Pall Corp.’s blood collection, filtration and processing product lines, according to a news release. The ...

Blood management systems provider Haemonetics Corp. of Braintree today announced acquisition of Engineering and Research Associates Inc.’s blood collection and processing business for $12.5 ...

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - specialty stocks, ...

Earnings call Haemonetics posted Q2 FY26 revenue of $327M, down 5% reported but up 9% organically ex-CSL. Adjusted EPS rose 13% to $1.27. Strong plasma and blood management growth offset IVT softness.

Haemonetics Corporation HAE announced receipt of the FDA 510(k) clearance for the TEG 6s hemostasis analyzer system Global Hemostasis-HN assay cartridge. This new cartridge expands Haemonetics' TEG 6s ...

We recently published a list of 10 Pro-Life Companies to Invest In Now. In this article, we are going to take a look at where Haemonetics Corporation (NYSE:HAE) stands against other top pro-life ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Haemonetics (HAE), which belongs to the Zacks ...